Oppenheimer Asset Management Inc. Has $2.43 Million Holdings in Exponent, Inc. (NASDAQ:EXPO)

Oppenheimer Asset Management Inc. trimmed its holdings in Exponent, Inc. (NASDAQ:EXPO) by 1.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,970 shares of the business services provider’s stock after selling 572 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Exponent were worth $2,429,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. State of Alaska Department of Revenue boosted its holdings in Exponent by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 5,946 shares of the business services provider’s stock valued at $481,000 after purchasing an additional 155 shares during the period. Everhart Financial Group Inc. acquired a new position in shares of Exponent during the first quarter valued at about $205,000. Fifth Third Bancorp lifted its stake in shares of Exponent by 14.4% in the first quarter. Fifth Third Bancorp now owns 6,835 shares of the business services provider’s stock valued at $554,000 after buying an additional 858 shares during the period. SG Americas Securities LLC acquired a new stake in Exponent during the first quarter worth about $665,000. Finally, Bridge City Capital LLC grew its position in Exponent by 0.5% during the first quarter. Bridge City Capital LLC now owns 53,545 shares of the business services provider’s stock worth $4,340,000 after buying an additional 259 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Insider Activity

In other news, VP John Pye sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 23rd. The stock was sold at an average price of $76.32, for a total value of $152,640.00. Following the sale, the vice president now directly owns 29,204 shares in the company, valued at approximately $2,228,849.28. This represents a 6.41% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Joseph Rakow sold 1,573 shares of the firm’s stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total value of $122,253.56. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,267 shares of company stock worth $489,120. 1.60% of the stock is currently owned by corporate insiders.

Exponent Stock Up 1.3%

Exponent stock opened at $75.94 on Friday. The business has a 50 day moving average price of $77.13 and a two-hundred day moving average price of $83.41. Exponent, Inc. has a 12 month low of $72.43 and a 12 month high of $115.75. The stock has a market cap of $3.85 billion, a price-to-earnings ratio of 37.04 and a beta of 0.92.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.04. The business had revenue of $137.44 million for the quarter, compared to analysts’ expectations of $134.63 million. Exponent had a return on equity of 25.33% and a net margin of 18.87%. Exponent’s quarterly revenue was up .2% on a year-over-year basis. During the same period in the previous year, the business posted $0.59 earnings per share. On average, analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.58%. The ex-dividend date was Friday, June 6th. Exponent’s dividend payout ratio (DPR) is presently 58.54%.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.